A detailed history of Nuveen, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Nuveen, LLC holds 654,072 shares of NTRA stock, worth $134 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
654,072
Previous 715,067 8.53%
Holding current value
$134 Million
Previous $121 Million 12.85%
% of portfolio
0.03%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

SELL
$133.66 - $181.11 $8.15 Million - $11 Million
-60,995 Reduced 8.53%
654,072 $105 Million
Q2 2025

Aug 12, 2025

SELL
$132.23 - $171.87 $11.5 Million - $14.9 Million
-86,677 Reduced 10.81%
715,067 $121 Million
Q1 2025

May 12, 2025

BUY
$132.63 - $177.0 $106 Million - $142 Million
801,744 New
801,744 $113 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Nuveen, LLC Portfolio

Follow Nuveen, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen, LLC with notifications on news.